Monitoring Emerging Human Immunodeficiency Virus Drug Resistance in Sub-Saharan Africa in the Era of Dolutegravir
- PMID: 34282844
- DOI: 10.1093/infdis/jiab382
Monitoring Emerging Human Immunodeficiency Virus Drug Resistance in Sub-Saharan Africa in the Era of Dolutegravir
Abstract
Dolutegravir-based regimens are now standard of care for human immunodeficiency virus treatment for millions of people around sub-Saharan Africa. To ensure its continued efficacy, monitoring of emerging drug resistance that inform a treatment strategy among those failing is crucial. In this report, we outline the US President's Emergency Plan for AIDS Relief to leverage viral load infrastructure to implement effective drug resistance surveillance in the countries it supports.
Keywords: HIVDR; dolutegravir; surveillance.
Published by Oxford University Press for the Infectious Diseases Society of America 2021.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
